The University of South Alabama (USA) is enrolled in the National Cancer Institute Central Institutional Review Board (NCI CIRB) Initiative. The USA IRB may carry out "Administrative Review" of certain NCI-sponsored Cooperative Group research studies approved by the CIRB, and once the USA IRB is satisfied that all local context issues have been met, will acknowledge the NCI CIRB as the IRB of Record for the study at USA. The USA IRB retains responsibilities for local oversight and review of the performance of the research after acceptance of Administrative Review. The instructions and documentation for submissions are below.
Be sure to review the complete USA policy and procedure for the use of the NCI CIRB.
Research sponsored by National Cancer Institute (NCI) are eligible for review by the NCI CIRB. When planning to initiate a NCI sponsored cooperative group trial, consult the NCI CIRB website to see if the trial is listed on the menu of CIRB approved trials.
Studies which involve any of the following are not eligible for submission to NCI CIRB:
1. Research involving prisoners
2. Planned emergency research
3. Single patient emergency use or compassionate use situations
4. Investigator-initiated research
USA may also require dual review by the USA IRB when the institution deems that the rights and welfare of subjects would be better served by local review.
Before you can submit to NCI CIRB, you must have access to the CIRB IRBManager. In order to gain access to IRBManager, you must first have a CTSU person ID, an active CTEP-IAM account, and listed on the CIRB roster for your site.
- To obtain or update IAM credentials, including the user name and password necessary to log into the CTSU website, visit the IAM registration page: https://ctepcore.nci.nih.gov/iam
- Once you receive an email with your CTSU log-on, you can be added to the CIRB Roster via the RUMS Roster. Contact your site RUMS administrator to update the roster.
Submitting to NCI CIRB
|Steps||Create a New Project in IRBNet|
|Step 1: Investigator begins LOCAL processes for submission to USA IRB||
|Step 2: Submission to NCI CIRB||
NOTE: If someone other than the Principal Investigator submits the Study-Specific Worksheet, IRBManager will automatically generate an email to the Investigator requesting review, confirm intent to comply, and submission of the Worksheet in IRBManager. The Investigator must click the SUBMIT button on the final page or the form will not be submitted.
|Step 3: Review by NCI CIRB||
What happens after you submit to the NCI CIRB?
Consent Documents: For NCI CIRB approved projects, the NCI CIRB document submitted to USA IRB in step 1 should be used for enrolling subjects. The USA IRB is not the IRB of record for the protocol, and will not be USA stamped.
NOTE: Commencement of project should not begin until all approvals and the clinical trial agreement are in place.
The NCI CIRB is now the IRB of records for your study. You should refer to NCI CIRB’s policy and procedures for their reporting requirements of continuing review, amendments, adverse events, protocol deviations, closure notifications, and any other submissions.
However, the USA IRB must still ensure adequate institutional oversight of research activities. Therefore, in addition to notifying NCI CIRB, investigators should notify the USA IRB of any of the following events:
- Protocol deviations that may represent a systematic problem requiring local evaluation by USA IRB to determine that sufficient local resources are available for safe conduct of the study
- Study holds or suspensions that are not built into the study design from CIRB or Sponsor (eg: interim analysis or enrollment complete need not be reported)
- Study Closure
- Study Terminations from CIRB or sponsor
- Subject complaints
- Amendment to change PI or key personnel (NOTE: IRB Application Part A must be updated to reflect personnel changes)
- Conflict of Interest updates
- Breaches of confidentiality/HIPAA Privacy and/or Security violations
- Completion of annual check-in form (more information below)
Annual Check-In: This is not the same as a continuing review. Therefore, it may occur at a different time than the continuing review required by NCI CIRB.
Project Personnel Updates: USA IRB application Part A should be updated, as needed, (i.e., study personnel, PI change and submitted to USA IRB)
Monitoring of NCI CIRB Approval Protocols: NCI CIRB will arrange for monitoring ongoing research, as its policies and procedures require. The USA IRB/ Office of Research Compliance and Assurance may monitor any CIRB approved protocol as part of its quality assurance program.
Record Keeping: Record keeping procedures for all files must be established, and CIRB documents, e-mail notifications, and other correspondence must be stored / filed as previously maintained through normal USA IRB approval.
The USA IRB local context consent language for NCI CIRB provides an outline of sections which may need to be included in your consent form. All sections may not be applicable, rather they are dependent on the study to be conducted.
Review the USA IRB Local Context Language for NCI CIRB to determine what specific USA language is required to be in the consent form. Generally, the HIPAA, Research Related Injury, Bill of Rights, ClinicalTrials.gov reporting, Reportable Income, and Source of Funding is required for the majority of studies.
NOTE: The NCI IRB does not permit HIPAA and GINA language to be a part of the consent document. Rather, these must be separate forms.
For questions concerning submission or reporting requirements of the USA IRB:
USA IRB Compliance Specialist
Office of Research Compliance and Assurance
For questions or concerns regarding submission or reporting requirements of the NCI CIRB:
NCI CIRB Helpdesk